These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 23523615)
1. Differential sensitivities of glioblastoma cell lines towards metabolic and signaling pathway inhibitions. Kennedy CR; Tilkens SB; Guan H; Garner JA; Or PM; Chan AM Cancer Lett; 2013 Aug; 336(2):299-306. PubMed ID: 23523615 [TBL] [Abstract][Full Text] [Related]
2. Glycolytic inhibitor 2-Deoxy-d-Glucose activates migration and invasion in glioblastoma cells through modulation of the miR-7-5p/TFF3 signaling pathway. Shukla A; Gupta P; Singh R; Mishra DP Biochem Biophys Res Commun; 2018 May; 499(4):829-835. PubMed ID: 29621542 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin. Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886 [TBL] [Abstract][Full Text] [Related]
4. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion. Miekus K; Kijowski J; Sekuła M; Majka M Oncol Rep; 2012 Nov; 28(5):1903-9. PubMed ID: 22941268 [TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target. Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of NADPH Oxidase-4 Potentiates 2-Deoxy-D-Glucose-Induced Suppression of Glycolysis, Migration, and Invasion in Glioblastoma Cells: Role of the Akt/HIF1α/HK-2 Signaling Axis. Gupta P; Jagavelu K; Mishra DP Antioxid Redox Signal; 2015 Sep; 23(8):665-81. PubMed ID: 25891245 [TBL] [Abstract][Full Text] [Related]
8. Targeted inhibition of dominant PI3-kinase catalytic isoforms increase expression of stem cell genes in glioblastoma cancer stem cell models. Jones NM; Rowe MR; Shepherd PR; McConnell MJ Int J Oncol; 2016 Jul; 49(1):207-16. PubMed ID: 27176780 [TBL] [Abstract][Full Text] [Related]
9. The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes. Xing F; Luan Y; Cai J; Wu S; Mai J; Gu J; Zhang H; Li K; Lin Y; Xiao X; Liang J; Li Y; Chen W; Tan Y; Sheng L; Lu B; Lu W; Gao M; Qiu P; Su X; Yin W; Hu J; Chen Z; Sai K; Wang J; Chen F; Chen Y; Zhu S; Liu D; Cheng S; Xie Z; Zhu W; Yan G Cell Rep; 2017 Jan; 18(2):468-481. PubMed ID: 28076790 [TBL] [Abstract][Full Text] [Related]
10. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma. Grzmil M; Morin P; Lino MM; Merlo A; Frank S; Wang Y; Moncayo G; Hemmings BA Cancer Res; 2011 Mar; 71(6):2392-402. PubMed ID: 21406405 [TBL] [Abstract][Full Text] [Related]